GOALS & OBJECTIVES
Caring for the Medically Ill: Improvements in the Management of Thromboembolic Disease
Highlights from the 2002 Annual Session of the American College of Physicians - American Society of Internal Medicine (ACP-ASIM)
Activity Date: August 2002  — Activity Info: Volume2, (12)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity

 

GOAL
To provide physicians with current information on the management of thromboembolic disease.

TARGET AUDIENCE
This activity is designed for cardiologists, orthopedic surgeons, general surgeons, emergency medicine practitioners, family practice physicians, internal medicine physicians, clinical pharmacists, and pharmacy services directors.

LEARNING OBJECTIVES
After reading this issue, the participant should be able to:

  • Discuss the clinical importance of venous thromboembolism in hospitalized patients with medical illness.
  • Summarize the results of trials addressing different approaches to thromboprophylaxis in hospitalized patients with medical illness.
  • Describe the design of ongoing clinical trials evaluating the role of prolonged thromboprophylaxis in hospitalized medical patients.
  • Analyze the data supporting the safety and efficacy of in-and outpatient treatment of deep vein thrombosis (DVT) with low-molecular-weight heparin-containing regimens.
  • Identify risk stratification for DVT among hospitalized medical and surgical patients.

ACCREDITATION STATEMENT
This activity has been planned and produced in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. The Johns Hopkins School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this continuing medical education activity for a maximum of 1 hour in Category 1 credit toward the American Medical Association Physicians’ Recognition Award. Each physician should claim only those hours of credit that are actually spent on the educational activity. Credits are available until the expiration date of August 31, 2004.

This continuing education activity was produced under the supervision of Bruce Perler, MD, Professor of Surgery, Johns Hopkins University School of Medicine and Charles Locke, MD, Assistant Professor, Internal Medicine, Johns Hopkins University School of Medicine.

This program is approved for 1 hours of credit (0.1 CEUs) and is co-sponsored by The University of Tennessee College of Pharmacy who is approved by the American Council on Pharmaceutical Education as a provider of continuing pharmaceutical education. ACPE Program #064-999-02-238-H01.

This continuing pharmacy education activity was produced under the supervision of Glen E. Farr, PharmD, Associate Dean of Continuing Education, University of Tennessee College of Pharmacy.

This program is supported by an unrestricted educational grant from Aventis Pharmaceuticals.

Publisher's Note and Disclaimer: The opinions expressed in this issue are those of the authors, presenters, and/or panelists and are not attributable to the publisher, editor, advisory board of Advanced Studies in Medicine, or The Johns Hopkins University School of Medicine or its Office of Continuing Medical Education. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this issue are not necessarily the same as indicated in the package insert for the product and may reflect the clinical experience of the authors, presenters, and/or panelists or may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Advanced Studies in Medicine (ISSN-1530-3004) is published by Galen Publishing, LLC, an HMG Company. P.O. Box 340, Somerville, NJ 08876. (908) 253-9001. Web site: www.galenpublishing.com. Copyright ©2001 by Galen Publishing, LLC. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. Bulk postage paid at Somerville, NJ Post Office and at additional mailing offices. Advanced Studies in Medicine is a registered trademark of The Healthcare Media Group, LLC. Printed on acid-free paper. BPA Membership applied for December 2000.

     
Home | Contact Us | View Account | Need Help?